Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
LY3200882 is an ATP-competitive inhibitor of TGF-β receptor type 1 (TGF-βRI).1 It inhibits TGF-β-induced SMAD phosphorylation in vitro and in vivo and exhibits antitumor activity in the 4T1-LP triple negative breast cancer orthotopic tumor model.
WARNING This product is not for human or veterinary use.
1. Abstract 955: LY3200882, a novel, highly selective TGFβRI small molecule inhibitor. Cancer Res. 77(13 Supp), (2017).